Cargando…

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes

BACKGROUND: It is presently unclear whether glycemic variability is associated with diabetic cardiovascular autonomic neuropathy (CAN). The aim of this study was to examine whether short- and/or long-term glycemic variability (GV) contribute to CAN. METHODS: A total of 110 patients with type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Ji Eun, Jin, Sang-Man, Baek, Jongha, Oh, Sewon, Hur, Kyu Yeon, Lee, Myung-Shik, Lee, Moon-Kyu, Kim, Jae Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462181/
https://www.ncbi.nlm.nih.gov/pubmed/26041130
http://dx.doi.org/10.1186/s12933-015-0233-0
_version_ 1782375627571068928
author Jun, Ji Eun
Jin, Sang-Man
Baek, Jongha
Oh, Sewon
Hur, Kyu Yeon
Lee, Myung-Shik
Lee, Moon-Kyu
Kim, Jae Hyeon
author_facet Jun, Ji Eun
Jin, Sang-Man
Baek, Jongha
Oh, Sewon
Hur, Kyu Yeon
Lee, Myung-Shik
Lee, Moon-Kyu
Kim, Jae Hyeon
author_sort Jun, Ji Eun
collection PubMed
description BACKGROUND: It is presently unclear whether glycemic variability is associated with diabetic cardiovascular autonomic neuropathy (CAN). The aim of this study was to examine whether short- and/or long-term glycemic variability (GV) contribute to CAN. METHODS: A total of 110 patients with type 2 diabetes who underwent three-day continuous glucose monitoring (CGM) completed five standardized autonomic neuropathy tests. Short-term GV was measured by the standard deviation (SD), coefficient of variation (CV) of glucose, and the mean amplitude of glycemic excursions (MAGE) in CGM. HbA1c variability was calculated from the intrapersonal SD, adjusted SD, and CV of serial HbA1c over 2-year period. CAN was defined as the presence of at least two abnormal parasympathetic function tests. The severity of CAN was evaluated by total scores of five autonomic function tests. RESULTS: In univariate analysis, not only SD and CV in CGM but also all parameters of HbA1c variability were significantly higher in the patients with CAN (n = 47, 42.7 %) than in those without CAN. In multivariate analysis, CV (Odds ratio [OR] 1.07, 95 % confidence interval [CI] 1.01–1.13; p = 0.033), but neither SD nor MAGE in CGM, independently correlated with the presence of CAN. All parameters of HbA1c variability, such as SD of HbA1c (OR 12.10 [95 % CI 2.29–63.94], p = 0.003), adjusted SD of HbA1c (OR 17.02 [95 % CI 2.66–108.86], p = 0.003), and log CV of HbA1c (OR 24.00 [95 % CI 3.09–186.48], p = 0.002), were significantly associated with the presence of CAN. The patients with higher HbA1c variability had an increased risk of advanced CAN. CONCLUSION: CV in CGM and all parameters of HbA1c variability were independently associated with the presence of CAN in patients with inadequately controlled type 2 diabetes requiring CGM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-015-0233-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4462181
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44621812015-06-11 The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes Jun, Ji Eun Jin, Sang-Man Baek, Jongha Oh, Sewon Hur, Kyu Yeon Lee, Myung-Shik Lee, Moon-Kyu Kim, Jae Hyeon Cardiovasc Diabetol Original Investigation BACKGROUND: It is presently unclear whether glycemic variability is associated with diabetic cardiovascular autonomic neuropathy (CAN). The aim of this study was to examine whether short- and/or long-term glycemic variability (GV) contribute to CAN. METHODS: A total of 110 patients with type 2 diabetes who underwent three-day continuous glucose monitoring (CGM) completed five standardized autonomic neuropathy tests. Short-term GV was measured by the standard deviation (SD), coefficient of variation (CV) of glucose, and the mean amplitude of glycemic excursions (MAGE) in CGM. HbA1c variability was calculated from the intrapersonal SD, adjusted SD, and CV of serial HbA1c over 2-year period. CAN was defined as the presence of at least two abnormal parasympathetic function tests. The severity of CAN was evaluated by total scores of five autonomic function tests. RESULTS: In univariate analysis, not only SD and CV in CGM but also all parameters of HbA1c variability were significantly higher in the patients with CAN (n = 47, 42.7 %) than in those without CAN. In multivariate analysis, CV (Odds ratio [OR] 1.07, 95 % confidence interval [CI] 1.01–1.13; p = 0.033), but neither SD nor MAGE in CGM, independently correlated with the presence of CAN. All parameters of HbA1c variability, such as SD of HbA1c (OR 12.10 [95 % CI 2.29–63.94], p = 0.003), adjusted SD of HbA1c (OR 17.02 [95 % CI 2.66–108.86], p = 0.003), and log CV of HbA1c (OR 24.00 [95 % CI 3.09–186.48], p = 0.002), were significantly associated with the presence of CAN. The patients with higher HbA1c variability had an increased risk of advanced CAN. CONCLUSION: CV in CGM and all parameters of HbA1c variability were independently associated with the presence of CAN in patients with inadequately controlled type 2 diabetes requiring CGM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-015-0233-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-04 /pmc/articles/PMC4462181/ /pubmed/26041130 http://dx.doi.org/10.1186/s12933-015-0233-0 Text en © Jun et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Jun, Ji Eun
Jin, Sang-Man
Baek, Jongha
Oh, Sewon
Hur, Kyu Yeon
Lee, Myung-Shik
Lee, Moon-Kyu
Kim, Jae Hyeon
The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
title The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
title_full The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
title_fullStr The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
title_full_unstemmed The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
title_short The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
title_sort association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462181/
https://www.ncbi.nlm.nih.gov/pubmed/26041130
http://dx.doi.org/10.1186/s12933-015-0233-0
work_keys_str_mv AT junjieun theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT jinsangman theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT baekjongha theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT ohsewon theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT hurkyuyeon theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT leemyungshik theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT leemoonkyu theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT kimjaehyeon theassociationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT junjieun associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT jinsangman associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT baekjongha associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT ohsewon associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT hurkyuyeon associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT leemyungshik associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT leemoonkyu associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes
AT kimjaehyeon associationbetweenglycemicvariabilityanddiabeticcardiovascularautonomicneuropathyinpatientswithtype2diabetes